CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

di Bravaccini, Sara, Maltoni, Roberta
Pubblicato in Breast Cancer Res (2019)

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

di Rocca, Andrea, Maltoni, Roberta, Bravaccini, Sara, Donati, Caterina, Andreis, Daniele
Pubblicato in Cancer Manag Res (2018)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold

di Maltoni, Roberta, Palleschi, Michela, Ravaioli, Sara, Tumedei, Maria Maddalena, Altini, Mattia, Bravaccini, Sara
Pubblicato in Diagn Pathol (2020)

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

di Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
Pubblicato in Ther Adv Med Oncol (2016)

Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report

di Maltoni, Roberta, Palleschi, Michela, Gallerani, Giulia, Bravaccini, Sara, Cecconetto, Lorenzo, Melegari, Elisabetta, Altini, Mattia, Rocca, Andrea
Pubblicato in Medicine (Baltimore) (2020)

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy

di Ravaioli, Sara, Tumedei, Maria Maddalena, Foca, Flavia, Maltoni, Roberta, Rocca, Andrea, Massa, Ilaria, Pietri, Elisabetta, Bravaccini, Sara
Pubblicato in Int J Exp Pathol (2017)

Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report

di Palleschi, Michela, Maltoni, Roberta, Barzotti, Eleonora, Melegari, Elisabetta, Curcio, Annalisa, Cecconetto, Lorenzo, Sarti, Samanta, Manunta, Silvia, Rocca, Andrea
Pubblicato in World J Clin Cases (2020)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

di Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Pubblicazione 2006-03-01

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

di Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Scarpi, Emanuela, Bonafè, Massimiliano, Puccetti, Maurizio, Maltoni, Roberta, Andreis, Daniele, Martinelli, Giovanni, Bravaccini, Sara
Pubblicato in J Oncol (2019)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

di Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Pubblicazione 2006

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

di Maltoni, Roberta, Palleschi, Michela, Ravaioli, Sara, Tumedei, Maria Maddalena, Rocca, Andrea, Melegari, Elisabetta, Altini, Mattia, Puccetti, Maurizio, Manunta, Silvia, Bravaccini, Sara
Pubblicato in Cell Transplant (2020)

Single shot ultrasound-guided thoracic paravertebral block for opioid-free radical mastectomy: a prospective observational study

di Santonastaso, Domenico P, de Chiara, Annabella, Russo, Emanuele, Musetti, Giovanni, Lucchi, Leonardo, Sibilio, Andrea, Maltoni, Roberta, Gamberini, Emiliano, Fusari, Maurizio, Agnoletti, Vanni
Pubblicato in J Pain Res (2019)

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

di Rossi, Tania, Gallerani, Giulia, Angeli, Davide, Cocchi, Claudia, Bandini, Erika, Fici, Pietro, Gaudio, Michele, Martinelli, Giovanni, Rocca, Andrea, Maltoni, Roberta, Fabbri, Francesco
Pubblicato in Cancers (Basel) (2020)

Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient

di Rossi, Tania, Palleschi, Michela, Angeli, Davide, Tebaldi, Michela, Martinelli, Giovanni, Vannini, Ivan, Puccetti, Maurizio, Limarzi, Francesco, Maltoni, Roberta, Gallerani, Giulia, Fabbri, Francesco
Pubblicato in Front Med (Lausanne) (2021)

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

di Zoli, Wainer, Ulivi, Paola, Tesei, Anna, Fabbri, Francesco, Rosetti, Marco, Maltoni, Roberta, Giunchi, Donata Casadei, Ricotti, Luca, Brigliadori, Giovanni, Vannini, Ivan, Amadori, Dino
Pubblicazione 2005

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer

di Maltoni, Roberta, Casadio, Valentina, Ravaioli, Sara, Foca, Flavia, Tumedei, Maria Maddalena, Salvi, Samanta, Martignano, Filippo, Calistri, Daniele, Rocca, Andrea, Schirone, Alessio, Amadori, Dino, Bravaccini, Sara
Pubblicato in Oncotarget (2017)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study

di Mercatali, Laura, Ricci, Marianna, Scarpi, Emanuela, Serra, Patrizia, Fabbri, Francesca, Ricci, Rossana, Liverani, Chiara, Zanoni, Michele, Zoli, Wainer, Maltoni, Roberta, Gunelli, Erica, Amadori, Dino, Ibrahim, Toni
Pubblicazione 2013

miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines

di Bandini, Erika, Fanini, Francesca, Vannini, Ivan, Rossi, Tania, Plousiou, Meropi, Tumedei, Maria Maddalena, Limarzi, Francesco, Maltoni, Roberta, Fabbri, Francesco, Hrelia, Silvana, Cho, William C. S., Fabbri, Muller
Pubblicato in Front Cell Dev Biol (2020)

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

di Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino
Pubblicato in Cancer Chemother Pharmacol (2017)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

di Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea
Pubblicato in Transl Oncol (2018)